![Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT) | American Journal of Neuroradiology Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT) | American Journal of Neuroradiology](http://www.ajnr.org/content/ajnr/early/2018/03/29/ajnr.A5619/F1.large.jpg)
Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT) | American Journal of Neuroradiology
![Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram](https://www.researchgate.net/publication/282658430/figure/fig1/AS:614292030255134@1523470041367/Patient-disposition-FAS-full-analysis-set-PPS-per-protocol-set-SAS-safety-analysis.png)
Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram
![Subject disposition. AE adverse event, FAS full analysis set, PPAS per... | Download Scientific Diagram Subject disposition. AE adverse event, FAS full analysis set, PPAS per... | Download Scientific Diagram](https://www.researchgate.net/publication/305749526/figure/fig2/AS:390949709598723@1470221082109/Subject-disposition-AE-adverse-event-FAS-full-analysis-set-PPAS-per-protocol-analysis.png)
Subject disposition. AE adverse event, FAS full analysis set, PPAS per... | Download Scientific Diagram
![Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study - ScienceDirect Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879822006902-fx1.jpg)
Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study - ScienceDirect
![The All Randomized/Full Analysis Set (ICH E9)—May Patients Be Excluded from the Analysis?* | Semantic Scholar The All Randomized/Full Analysis Set (ICH E9)—May Patients Be Excluded from the Analysis?* | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a000d1a89a3db891de4b3bb3228abdc3279a2e86/2-Table1-1.png)
The All Randomized/Full Analysis Set (ICH E9)—May Patients Be Excluded from the Analysis?* | Semantic Scholar
![Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/c0a81b87-8ceb-4bbf-a493-55c6d4121bf6/gr1_lrg.jpg)
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity
![Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram](https://www.researchgate.net/publication/51712568/figure/fig3/AS:280374765735962@1443857961681/Patient-disposition-SAF-safety-analysis-set-FAS-full-analysis-set-PPS-per-protocol.png)
Patient disposition. SAF, safety analysis set; FAS, full analysis set;... | Download Scientific Diagram
![Intention to treat and per protocol analysis in clinical trials - Tripepi - 2020 - Nephrology - Wiley Online Library Intention to treat and per protocol analysis in clinical trials - Tripepi - 2020 - Nephrology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6e770d34-cd81-437d-9460-5c8b164757e4/nep.v25.7.cover.jpg)
Intention to treat and per protocol analysis in clinical trials - Tripepi - 2020 - Nephrology - Wiley Online Library
![PPT - Robert O'Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA PowerPoint Presentation - ID:9487710 PPT - Robert O'Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA PowerPoint Presentation - ID:9487710](https://image5.slideserve.com/9487710/roles-of-the-different-analysis-sets-l.jpg)
PPT - Robert O'Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA PowerPoint Presentation - ID:9487710
![Figure 1 | Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis | SpringerLink Figure 1 | Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13075-018-1772-z/MediaObjects/13075_2018_1772_Fig1_HTML.png)
Figure 1 | Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis | SpringerLink
![Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram](https://www.researchgate.net/publication/43131752/figure/fig1/AS:203148061876225@1425445680040/Subject-disposition-FAS-full-analysis-set-PP-per-protocol-ITT-intention-to-treat.png)
Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram
![Toxins | Free Full-Text | Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study Toxins | Free Full-Text | Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study](https://www.mdpi.com/toxins/toxins-14-00730/article_deploy/html/images/toxins-14-00730-g001.png)
Toxins | Free Full-Text | Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study
![INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD | European Respiratory Society INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD | European Respiratory Society](https://erj.ersjournals.com/content/erj/44/6/1548/F2.large.jpg)
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD | European Respiratory Society
![Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study | Arthritis Research & Therapy | Full Text Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study | Arthritis Research & Therapy | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13075-019-1960-5/MediaObjects/13075_2019_1960_Fig1_HTML.png)
Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study | Arthritis Research & Therapy | Full Text
![Definition of the analyzed populations. FAS = full analysis set; PP =... | Download Scientific Diagram Definition of the analyzed populations. FAS = full analysis set; PP =... | Download Scientific Diagram](https://www.researchgate.net/publication/325138414/figure/fig3/AS:626359730724864@1526347205934/Definition-of-the-analyzed-populations-FAS-full-analysis-set-PP-per-protocol.png)
Definition of the analyzed populations. FAS = full analysis set; PP =... | Download Scientific Diagram
![Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram](https://www.researchgate.net/publication/43131752/figure/fig1/AS:203148061876225@1425445680040/Subject-disposition-FAS-full-analysis-set-PP-per-protocol-ITT-intention-to-treat_Q320.jpg)